IP Verse

Secerna competitive analysis

Latest publications and patents of Secerna New

Explore the latest publications and patents granted to Secerna, showcasing their recent innovations and technological advancements.

Latest oppositions filed by Secerna

Explore patent oppositions filed by Secerna against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 9, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3506931
Methods For Preventing Or Treating Allergy By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSApr 30, 2025
EP3889181
Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSJan 23, 2025
EP3110848
Methods For Treating Skin Infection By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSNov 13, 2024
EP3515465
Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorREGENERON PHARMACEUTICALSNov 6, 2024
EP3973987
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSOct 9, 2024
EP4011915
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSJul 10, 2024
EP3470432
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSJul 5, 2022
EP2872171
Toxicity Management For Anti-Tumor Activity Of CarsTHE CHILDRENS HOSPITAL OF PHILADELPHIAOct 5, 2021
EP3338794
Toxicity Management For Anti-Tumor Activity Of CarsTHE CHILDRENS HOSPITAL OF PHILADELPHIANov 26, 2020
EP3312196
Antibodies Against Cd38 For Treatment Of Multiple MyelomaGENMABApr 16, 2020

Latest PTAB cases involving Secerna

Discover the latest PTAB cases involving Secerna, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Secerna with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 9, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
SECERNA11 - - - Highly Aggressive
GENMAB67 - - Aggressive
REGENERON PHARMACEUTICALS3893930Balanced
SANOFI BIOTECHNOLOGY - 50 - - Non-Active